Skip to main navigation
Rein Therapeutics corporate website
Rein Therapeutics corporate website
  • 01

    Home

  • 02

    Science

  • 03

    Pipeline

  • 04

    Company

  • 05

    Investors & Media

Visit our X account
Visit our LinkedIn profile
Investors & Media
  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Info
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Governance
    • Documents & Charters
    • Board and Leadership Team
    • Committee Composition
  • Financial Info
    • SEC Filings
    • Form 8937
    • Annual Reports
  • Investor Info
    • Information Request
    • IR Contact
    • Email Alerts
    • Investor FAQs

Events & Presentations

Upcoming Events

H.C. Wainwright 28th Annual Global Investment Conference
September 14, 2026 11:00 AM EDT

Read More

Past Events

2026 Cantor Global Healthcare Conference
September 11, 2026 8:00 AM EDT

Read More

Presentations

Rein Therapeutics Scientific Presentation September 2026
September 4, 2026

Download

Rein Therapeutics Corporate Presentation
August 19, 2026

Download

IPF Summit 2025: Innovating Clinical Trial Design in IPF: Lessons from LTI-03
August 21, 2025

Download

ATS 2025: Pre-clinical Proof-of-concept of Anti-fibrotic Activity Of Caveolin-1 Scaffolding Domain Peptide LTI-03 In Ex Vivo Precision Cut Lung Slices From Patients With Idiopathic Pulmonary Fibrosis
May 19, 2025

Download

ATS 2025: Evaluating alveolar regenerative properties of caveolin-1 scaffolding domain (CSD) peptides in three dimensional (3D) alveolospheres from IPF and normal donor lungs
May 19, 2025

Download

  • Science
  • Pipeline
  • Company
  • Investors & Media
Visit our X account
Visit our LinkedIn profile
Rein TherapeuticsTM 2026
  • Privacy Policy
Rein Therapeutics corporate website